|
JPS5328935B2
(https=)
|
1972-01-20 |
1978-08-17 |
|
|
|
JPS56104333A
(en)
|
1980-01-23 |
1981-08-20 |
Fuji Photo Film Co Ltd |
Color photographic sensitive material
|
|
DE3445669A1
(de)
|
1984-12-14 |
1986-06-19 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
JPS6232459A
(ja)
|
1985-08-05 |
1987-02-12 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS6238463A
(ja)
|
1985-08-14 |
1987-02-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−感光材料の画像形成方法
|
|
JPH067250B2
(ja)
|
1985-10-18 |
1994-01-26 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料
|
|
JPS6292939A
(ja)
|
1985-10-19 |
1987-04-28 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
|
JPH0756566B2
(ja)
|
1985-11-06 |
1995-06-14 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62129853A
(ja)
|
1985-11-30 |
1987-06-12 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
|
JPS62153953A
(ja)
|
1985-12-27 |
1987-07-08 |
Fuji Photo Film Co Ltd |
カラ−写真感光材料
|
|
JPS62173466A
(ja)
|
1986-01-28 |
1987-07-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS62222251A
(ja)
|
1986-02-17 |
1987-09-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62257158A
(ja)
|
1986-04-30 |
1987-11-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
DE3788600T2
(de)
|
1986-07-22 |
1994-04-28 |
Fuji Photo Film Co Ltd |
Verfahren zur Behandlung eines farbphotographischen Silberhalogenidmaterials.
|
|
DE3803775A1
(de)
|
1988-02-09 |
1989-08-17 |
Boehringer Mannheim Gmbh |
Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
|
JPH02234158A
(ja)
|
1989-03-07 |
1990-09-17 |
Fuji Photo Film Co Ltd |
カラー感光材料
|
|
JPH02264946A
(ja)
|
1989-04-05 |
1990-10-29 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
|
JPH02267548A
(ja)
|
1989-04-10 |
1990-11-01 |
Fuji Photo Film Co Ltd |
画像形成法
|
|
DE3925584A1
(de)
|
1989-08-02 |
1991-02-07 |
Boehringer Mannheim Gmbh |
Neue n-(dimethyloxophosphinylmethyl-)-lactame, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
DE4027592A1
(de)
|
1990-08-31 |
1992-03-05 |
Beiersdorf Ag |
Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
|
|
JPH04315148A
(ja)
|
1991-04-15 |
1992-11-06 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
|
GB9205702D0
(en)
|
1992-03-16 |
1992-04-29 |
Fujisawa Pharmaceutical Co |
A new use of a quinazoline derivative
|
|
DE69310098T2
(de)
|
1992-10-15 |
1997-07-31 |
Fuji Photo Film Co., Ltd., Minami-Ashigara, Kanagawa |
Verarbeitungsverfahren für farbphotographisches Silberhalogenidmaterial
|
|
JPH10501222A
(ja)
|
1994-05-27 |
1998-02-03 |
メルク エンド カンパニー インコーポレーテッド |
破骨細胞仲介骨吸収を抑制するための化合物
|
|
US5756502A
(en)
|
1994-08-08 |
1998-05-26 |
Warner-Lambert Company |
Quinazolinone derivatives as cholyecystokinin (CCK) ligands
|
|
TW381092B
(en)
*
|
1995-07-07 |
2000-02-01 |
Otsuka Pharma Co Ltd |
Novel benzimidazole derivatives for use in treating arteriosclerotic diseases
|
|
US5747235A
(en)
|
1996-01-26 |
1998-05-05 |
Eastman Kodak Company |
Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
|
|
JP2000505471A
(ja)
|
1996-02-28 |
2000-05-09 |
メルク エンド カンパニー インコーポレーテッド |
フィブリノーゲン受容体拮抗物質
|
|
US5780480A
(en)
|
1996-02-28 |
1998-07-14 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
CA2276081A1
(en)
|
1996-12-30 |
1998-07-09 |
Lekhanh O. Tran |
Inhibitors of farnesyl-protein transferase
|
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
|
EP1047691A1
(en)
|
1997-12-12 |
2000-11-02 |
Smithkline Beecham Plc |
Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists
|
|
BR9814375A
(pt)
|
1997-12-22 |
2002-05-21 |
Bayer Ag |
Inibição de raf cinase usando difenil uréias substituìdas simétricas e assimétricas
|
|
DE19839499A1
(de)
|
1998-08-29 |
2000-03-02 |
Merck Patent Gmbh |
2-Oxo-2H-chinolinderivate
|
|
US6777413B2
(en)
|
2000-02-01 |
2004-08-17 |
Millennium Pharmaceuticals, Inc. |
2-[1H]-quinolone and 2-[1H]-quinoxalone inhibitors of factor Xa
|
|
JP2002341484A
(ja)
|
2001-03-12 |
2002-11-27 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
|
JP2002296731A
(ja)
|
2001-03-30 |
2002-10-09 |
Fuji Photo Film Co Ltd |
熱現像カラー画像記録材料
|
|
WO2002090347A1
(en)
|
2001-04-30 |
2002-11-14 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds
|
|
MXPA03010436A
(es)
|
2001-05-15 |
2004-03-09 |
Du Pont |
Amidas biciclicas fusionadas a piridinilo como funguicidas.
|
|
JP2003321472A
(ja)
|
2002-02-26 |
2003-11-11 |
Takeda Chem Ind Ltd |
Ｇｒｋ阻害剤
|
|
EP1388342A1
(en)
|
2002-08-07 |
2004-02-11 |
Aventis Pharma Deutschland GmbH |
Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
|
|
US7825132B2
(en)
|
2002-08-23 |
2010-11-02 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibition of FGFR3 and treatment of multiple myeloma
|
|
CA2496164C
(en)
|
2002-08-23 |
2010-11-09 |
Chiron Corporation |
Benzimidazole quinolinones and uses thereof
|
|
WO2004026794A2
(en)
|
2002-09-17 |
2004-04-01 |
Merck & Co., Inc. |
Removal of aldehyde impurity by reactive polystyrene resin
|
|
WO2004052371A2
(en)
|
2002-12-11 |
2004-06-24 |
7Tm Pharma A/S |
Cyclic quinoline compounds for use in mch receptor related disorders
|
|
US20040142950A1
(en)
|
2003-01-17 |
2004-07-22 |
Bunker Amy Mae |
Amide and ester matrix metalloproteinase inhibitors
|
|
US7205318B2
(en)
|
2003-03-18 |
2007-04-17 |
Bristol-Myers Squibb Company |
Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors
|
|
JP4847868B2
(ja)
|
2003-05-14 |
2011-12-28 |
ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド |
化合物、及び、アミロイドベータの調節におけるその使用
|
|
ES2558761T3
(es)
|
2003-05-19 |
2016-02-08 |
Novartis Ag |
Compuestos y composiciones inmunosupresores
|
|
CN102225926A
(zh)
|
2003-11-07 |
2011-10-26 |
诺华疫苗和诊断公司 |
具有改进药物特性的喹啉酮类化合物的药学上可接受的盐
|
|
WO2005087742A1
(en)
|
2004-03-08 |
2005-09-22 |
Exelixis, Inc. |
Metabolic kinase modulators and methods of use as pesticides
|
|
WO2005094805A1
(ja)
|
2004-04-01 |
2005-10-13 |
Institute Of Medicinal Molecular Design. Inc. |
イミン誘導体及びアミド誘導体
|
|
JP2008501689A
(ja)
|
2004-06-03 |
2008-01-24 |
ブランデイス ユニヴァーシティー |
シンコナアルカロイドを基本構造とする二官能触媒を用いた不斉マイケル付加およびアルドール付加反応
|
|
GB0416730D0
(en)
|
2004-07-27 |
2004-09-01 |
Novartis Ag |
Organic compounds
|
|
EP1655295A1
(en)
*
|
2004-11-03 |
2006-05-10 |
Schering Aktiengesellschaft |
Anthranilamide pyridinureas as VEGF receptor kinase inhibitors
|
|
UY29198A1
(es)
|
2004-11-09 |
2006-05-31 |
Cancer Rec Tech Ltd |
Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones
|
|
US20060281763A1
(en)
|
2005-03-25 |
2006-12-14 |
Axon Jonathan R |
Carboxamide inhibitors of TGFbeta
|
|
GB0509224D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of intracellular enzymatic activity
|
|
GB0509227D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Intracellular enzyme inhibitors
|
|
WO2006130437A2
(en)
|
2005-05-27 |
2006-12-07 |
Brandeis University |
Asymmetric carbon-carbon-bond-forming reactions catalyzed by bifunctional cinchona alkaloids
|
|
WO2007035935A1
(en)
|
2005-09-23 |
2007-03-29 |
Coley Pharmaceutical Group, Inc. |
METHOD FOR 1H-IMIDAZO[4,5-c]PYRIDINES AND ANALOGS THEREOF
|
|
CA2640307A1
(en)
|
2006-02-16 |
2007-08-23 |
Syngenta Participations Ag |
Pesticides containing a bicyclic bisamide structure
|
|
GB0605689D0
(en)
|
2006-03-21 |
2006-05-03 |
Novartis Ag |
Organic compounds
|
|
US7601716B2
(en)
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
|
ATE528002T1
(de)
|
2006-05-19 |
2011-10-15 |
Bayer Pharma AG |
Pyridoncarboxamidderivate zur behandlung hyperproliferativer und angiogenese-vermittelter leiden
|
|
WO2008029152A2
(en)
|
2006-09-08 |
2008-03-13 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
|
CA2665438C
(en)
|
2006-10-04 |
2014-12-02 |
Tibotec Pharmaceuticals Ltd. |
Carboxamide 4-[(4-pyridyl)amino]pyrimidines useful as hcv inhibitors
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
AU2008219166B2
(en)
|
2007-02-16 |
2013-05-16 |
Amgen Inc. |
Nitrogen-containing heterocyclyl ketones and their use as c-Met inhibitors
|
|
AU2008223348A1
(en)
*
|
2007-03-07 |
2008-09-12 |
Alantos Pharmaceuticals Holding, Inc. |
Metalloprotease inhibitors containing a heterocyclic moiety
|
|
US8039505B2
(en)
|
2007-04-11 |
2011-10-18 |
University Of Utah Research Foundation |
Compounds for modulating T-cells
|
|
JP2008280341A
(ja)
|
2007-04-12 |
2008-11-20 |
Sumitomo Chemical Co Ltd |
ヒドラジド化合物およびその防除用途
|
|
US8975259B2
(en)
|
2007-04-27 |
2015-03-10 |
University Of Rochester |
Compositions and methods for inhibiting G protein signaling
|
|
EP2008658A1
(en)
|
2007-06-28 |
2008-12-31 |
Bayer Schering Pharma Aktiengesellschaft |
Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
|
|
MY162760A
(en)
|
2007-09-17 |
2017-07-14 |
Abbvie Bahamas Ltd |
Anti-infective agents and uses thereof
|
|
EP2297097A2
(en)
|
2008-06-11 |
2011-03-23 |
Irm Llc |
Compounds and compositions useful for the treatment of malaria
|
|
WO2010030967A1
(en)
|
2008-09-12 |
2010-03-18 |
Wyeth Llc |
4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents
|
|
WO2010045374A1
(en)
|
2008-10-15 |
2010-04-22 |
Gilead Palo Alto, Inc. |
3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors
|
|
BRPI0923498A2
(pt)
*
|
2008-12-23 |
2019-09-24 |
Hoffmann La Roche |
amidos de diidropiridona como moduladores de p2x7
|
|
BRPI1011477A2
(pt)
|
2009-03-02 |
2016-03-22 |
Sirtris Pharmaceuticals Inc |
quinolinas 8-substituidas e analogos relacionados como moduladores de sirtuina
|
|
US8278302B2
(en)
*
|
2009-04-08 |
2012-10-02 |
Boehringer Ingelheim International Gmbh |
Substituted piperidines as CCR3 antagonists
|
|
US8362249B2
(en)
*
|
2009-04-27 |
2013-01-29 |
Boehringer Ingelheim International Gmbh |
CXCR3 receptor antagonists
|
|
UA107360C2
(en)
|
2009-08-05 |
2014-12-25 |
Biogen Idec Inc |
Bicyclic aryl sphingosine 1-phosphate analogs
|
|
ES2563057T3
(es)
*
|
2009-11-05 |
2016-03-10 |
Glaxosmithkline Llc |
Inhibidor de bromodominio de benzodiazepina
|
|
US20130109672A1
(en)
|
2010-04-29 |
2013-05-02 |
The United States Of America,As Represented By The Secretary, Department Of Health And Human Service |
Activators of human pyruvate kinase
|
|
JP5960688B2
(ja)
|
2010-05-17 |
2016-08-02 |
インコゼン セラピューティクス プライベート リミテッド |
プロテインキナーゼ調節物質としての新規３，５−二置換−３ｈ−［１，２，３］トリアゾロ［４，５−ｂ］ピリジン化合物
|
|
WO2011156632A2
(en)
|
2010-06-09 |
2011-12-15 |
Georgetown University |
Compositions and methods of treatment for tumors in the nervous system
|
|
US20130137865A1
(en)
|
2010-08-11 |
2013-05-30 |
Taisho Pharmaceutical Co., Ltd. |
Heteroaryl-pyrazole derivative
|
|
AR084070A1
(es)
*
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
TW201307292A
(zh)
|
2010-12-17 |
2013-02-16 |
Hoffmann La Roche |
經取代之６，６－稠合含氮雜環化合物及其用途
|
|
TW201309639A
(zh)
|
2011-02-17 |
2013-03-01 |
Lg Life Sciences Ltd |
作為ｇｐｒ１１９促效劑之肟衍生物
|
|
WO2012125668A1
(en)
|
2011-03-17 |
2012-09-20 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
GB201106750D0
(en)
*
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
JP5742439B2
(ja)
|
2011-05-02 |
2015-07-01 |
信越化学工業株式会社 |
蛍光性化合物及び蛍光性樹脂組成物
|
|
JP6007417B2
(ja)
|
2011-05-31 |
2016-10-12 |
レセプトス エルエルシー |
新規ｇｌｐ−１受容体安定剤および調節剤
|
|
CN102887895B
(zh)
|
2011-07-22 |
2016-08-24 |
山东轩竹医药科技有限公司 |
吡啶并嘧啶类mTOR抑制剂
|
|
EP2736330A4
(en)
|
2011-07-29 |
2015-05-27 |
Tempero Pharmaceuticals Inc |
COMPOUNDS AND METHODS
|
|
WO2013027168A1
(en)
*
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
EP2766345B1
(en)
|
2011-10-14 |
2016-03-16 |
Bristol-Myers Squibb Company |
Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
|
|
US9278089B2
(en)
|
2011-10-26 |
2016-03-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method of treating HCV infection with a small molecule CHK2 inhibitor
|
|
IN2014MN01982A
(https=)
|
2012-04-25 |
2015-07-10 |
Raqualia Pharma Inc |
|
|
WO2014034719A1
(ja)
|
2012-08-29 |
2014-03-06 |
興和株式会社 |
Ｔｌｒ阻害作用を有するキノリン誘導体
|
|
WO2014095774A1
(de)
|
2012-12-20 |
2014-06-26 |
Bayer Pharma Aktiengesellschaft |
Bet-proteininhibitorische dihydropyridopyrazinone
|
|
HK1211033A1
(en)
|
2012-12-20 |
2016-05-13 |
Bayer Pharma Aktiengesellschaft |
Bet-protein-inhibiting dihydroquinoxalinones
|